The European Medicines Agency has recommended authorizing a twice-yearly injectable drug to prevent HIV. Scientists say this ...

An HIV prevention pill that could provide a month of protection per tablet has been given the green light to proceed to pivotal trials to test its efficacy. Spotlight reports on new findings on the ...

DAP Health has received the new twice-yearly injection for HIV prevention. Here's what you need to know if you're interested ...

The twice-yearly injectable drug’s potential could be compromised by the Trump administration’s dramatic cuts to HIV-prevention infrastructure in the U.S.

The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show prevents new infections.

The long fight against HIV/AIDS may get a potent new weapon. A new drug, taken by injection twice a year, shows great promise in preventing new HIV infections and would ease the treatment process ...

Californians, starting next year, will be able to access HIV prevention medications without a prescription. Gov. Gavin Newsom signed a bill into law on Monday, making California the first state in ...

The approval comes amid an expansion of HIV prevention options in the U.S. The U.S. Food and Drug Administration (FDA) has approved the first-ever long-acting injectable drug for HIV prevention ...

Why FDA approval of new HIV prevention drug is a big deal 02:25. The U.S. Food and Drug Administration has approved the drug lenacapavir as a twice-yearly injection to prevent HIV.